DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) Total debt
DexCom, Inc.'s total debt at the end of fiscal 2025 was $1.2B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $1.2B. Over the past ten years it has ranged from $2.3M (fiscal 2015) to $2.4B (fiscal 2023); the current reading is higher than 64% of that period. DexCom, Inc. ranks 16th of 147 Medical Devices companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.2B | 0.32% |
| FY2024 | $1.2B | (49.18%) |
| FY2023 | $2.4B | 23.54% |
| FY2022 | $2.0B | (1.62%) |
| FY2021 | $2.0B | 18.92% |
| FY2020 | $1.7B | 56.86% |
| FY2019 | $1.1B | 6.28% |
| FY2018 | $1.0B | 208.39% |
| FY2017 | $327.6M | 5,360.00% |
| FY2016 | $6.0M | 160.87% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $1.2B | 0.08% |
| Mar 2026 | $1.2B | 0.07% |
| Dec 2025 | $1.2B | 0.08% |
| Sep 2025 | $1.2B | 0.08% |
| 38 more quarters | Free account |
Against its own ten years
Low $2.3M
High $2.4B
Ten-year median
$1.2B
Current reading's percentile
64
Total debt against peers
| Company | Total debt |
|---|---|
| BSX Boston Scientific Corporation compare | $12.6B |
| GEHC GE HealthCare Technologies Inc. compare | $11.5B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $7.5B |
| PHG Koninklijke Philips N.V. compare | $7.3B |
| SNN Smith & Nephew SNATS, Inc. compare | $3.2B |
| STE STERIS plc compare | $1.9B |
| DXCM DexCom, Inc. | $1.2B |
| EW Edwards Lifesciences Corporation compare | $598.7M |
| PEN Penumbra, Inc. compare | $19.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on DXCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement